Anders Borgkvist
Principal Researcher
E-mail: anders.borgkvist@ki.se
Telephone: +46852487165
Visiting address: Solnavägen 9, 17165 Soln
Postal address: C4 Neurovetenskap, C4 Forskning Borgkvist, 171 77 Stockholm
Part of:
- Department of Neuroscience
- Anders Borgkvist group
Articles
- Article: CELL REPORTS. 2024;43(12):114997Carbonell-Roig J; Aaltonen A; Wilson K; Molinari M; Cartocci V; Mcguirt A; Mosharov E; Kehr J; Lieberman OJ; Sulzer D; Borgkvist A; Santini E
- Article: BIOLOGY OPEN. 2023;12(10):bio060113Mastropasqua F; Oksanen M; Soldini C; Alatar S; Arora A; Ballarino R; Molinari M; Agostini F; Poulet A; Watts M; Rabkina I; Becker M; Li D; Anderlid B-M; Isaksson J; Remnelius KL; Moslem M; Jacob Y; Falk A; Crosetto N; Bienko M; Santini E; Borgkvist A; Bo''lte S; Tammimies K
- Article: MOVEMENT DISORDERS. 2021;36(5):1137-1146Feyder M; Plewnia C; Lieberman OJ; Spigolon G; Piccin A; Urbina L; Dehay B; Li Q; Nilsson P; Altun M; Santini E; Sulzer D; Bezard E; Borgkvist A; Fisone G
- Article: FRONTIERS IN CELLULAR NEUROSCIENCE. 2020;14:70Lieberman OJ; Cartocci V; Pigulevskiy I; Molinari M; Carbonell J; Broseta MB; Post MR; Sulzer D; Borgkvist A; Santini E
- Article: ELIFE. 2020;9:e50843Lieberman OJ; Frier MD; McGuirt AF; Griffey CJ; Rafikian E; Yang M; Yamamoto A; Borgkvist A; Santini E; Sulzer D
- Article: NEURON. 2018;99(3):540-554.e4Lieberman OJ; McGuirt AF; Mosharov EV; Pigulevskiy I; Hobson BD; Choi S; Frier MD; Santini E; Borgkvist A; Sulzer D
- Article: CURRENT OPINION IN NEUROBIOLOGY. 2018;48:71-78Borgkvist A; Lieberman OJ; Sulzer D
- Article: NEUROPHARMACOLOGY. 2016;110(Pt A):386-395Avegno EM; Salling MC; Borgkvist A; Mrejeru A; Whitebirch AC; Margolis EB; Sulzer D; Harrison NL
- Article: NEURON. 2015;87(5):976-988Borgkvist A; Avegno EM; Wong MY; Kheirbek MA; Sonders MS; Hen R; Sulzer D
- Article: NEUROSCIENCE. 2015;290:594-607Wong MY; Borgkvist A; Choi SJ; Mosharov EV; Bamford NS; Sulzer D
- Journal article: BRAIN. 2014;137(Pt 8):2113-2115Borgkvist A; Mosharov EV; Sulzer D
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2013;110(3):870-875Rodriguez PC; Pereira DB; Borgkvist A; Wong MY; Barnard C; Sonders MS; Zhang H; Sames D; Sulzer D
- Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2012;15(4):531-540Borgkvist A; Malmlof T; Feltmann K; Lindskog M; Schilstrom B
- Journal article: NEURON. 2011;70(5):803-805Borgkvist A; Mrejeru A; Sulzer D
- Article: NEUROPSYCHOPHARMACOLOGY. 2009;34(7):1710-1720Bertran-Gonzalez J; Hakansson K; Borgkvist A; Irinopoulou T; Brami-Cherrier K; Usiello A; Greengard P; Herve D; Girault J-A; Valjent E; Fisone G
- Article: MOLECULAR AND CELLULAR NEUROSCIENCE. 2008;39(4):586-591Westerlund M; Ran C; Borgkvist A; Sterky FH; Lindqvist E; Lundstroemer K; Pernold K; Brene S; Kallunki P; Fisone G; Olson L; Galter D
- Article: NEUROSCIENCE. 2008;156(3):515-526Korhonen L; Hansson I; Maugras C; Wehrle R; Kairisalo M; Borgkvist A; Jokitalo E; Sotelo C; Fisone G; Dusart I; Lindholm D
- Article: NEUROPHARMACOLOGY. 2008;55(2):230-237Borgkvist A; Valjent E; Santini E; Herve D; Girault J-A; Fisone G
- Article: NEUROPHARMACOLOGY. 2008;54(5):815-823Marcellino D; Carriba P; Filip M; Borgkvist A; Frankowska M; Bellido I; Tanganelli S; Mueller CE; Fisone G; Lluis C; Agnati LF; Franco R; Fuxe K
- Article: MOLECULAR AND CELLULAR NEUROSCIENCE. 2008;37(2):335-345Errico F; Santini E; Migliarini S; Borgkvist A; Centonze D; Nasti V; Carta M; De Chiara V; Prosperetti C; Spano D; Herve D; Pasqualetti M; Di Lauro R; Fisone G; Usiello A
- Article: NEUROPHARMACOLOGY. 2008;54(1):31-35Borgkvist A; Marcellino D; Fuxe K; Greengard P; Fisone G
- Journal article: NEUROPSYCHOPHARMACOLOGY. 2007;32(11):2440Borgkvist A; Usiello A; Greengard P; Fisone G
- Article: PHYSIOLOGY & BEHAVIOR. 2007;92(1-2):8-14Fisone G; Hakansson K; Borgkvist A; Santini E
- Article: NEUROPSYCHOPHARMACOLOGY. 2007;32(9):1995-2003Borgkvist A; Usiello A; Greengard P; Fisone G
- Article: JOURNAL OF NEUROSCIENCE. 2007;27(26):6995-7005Santini E; Valjent E; Usiello A; Carta M; Borgkvist A; Girault J-A; Herve D; Greengard P; Fisone G
- Article: MOLECULAR AND CELLULAR NEUROSCIENCE. 2006;31(2):293-302Borgkvist A; Puelles E; Carta M; Acampora D; Ang SL; Wurst W; Goiny M; Fisone G; Simeone A; Usiello A
- Article: JOURNAL OF NEUROSCIENCE. 2005;25(37):8432-8438Andersson M; Usiello A; Borgkvist A; Pozzi L; Dominguez C; Fienberg AA; Svenningsson P; Fredholm BB; Borrelli E; Greengard P; Fisone G
- Article: JOURNAL OF NEUROCHEMISTRY. 2003;86(2):451-459Pozzi L; Håkansson K; Usiello A; Borgkvist A; Lindskog M; Greengard P; Fisone G
- Show more
All other publications
- Preprint: BIORXIV. 2025Aaltonen A; Tamaki A; Ramón AP; Borgkvist A; Santini E
- Preprint: BIORXIV. 2024;BIORXIVMolinari M; Lieberman OJ; Sulzer D; Santini E; Borgkvist A
- Preprint: BIORXIV. 2024;BIORXIVCarbonell-Roig J; Aaltonen A; Cartocci V; McGuirt A; Mosharov E; Kehr J; Lieberman OJ; Sulzer D; Borgkvist A; Santini E
- Preprint: BIORXIV. 2022Mastropasqua F; Oksanen M; Soldini C; Alatar S; Arora A; Ballarino R; Molinari M; Agostini F; Poulet A; Watts M; Rabkina I; Becker M; Li D; Anderlid B-M; Isaksson J; Remnelius KL; Moslem M; Jacob Y; Falk A; Crosetto N; Bienko M; Santini E; Borgkvist A; Bölte S; Tammimies K
- Book chapter: THE OXFORD HANDBOOK OF NEURONAL PROTEIN SYNTHESIS. 2021;p. 451-486Santini E; Borgkvist A
- Review: MOVEMENT DISORDERS. 2015;30(1):45-53Mosharov EV; Borgkvist A; Sulzer D
- Doctoral thesis: 2008Borgkvist A
- Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2008;18:S5-S6Borgkvist A; Nestler EJ; Greengard P; Fisone G; Brene S
- Published conference paper: NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007;31(1):79-88Borgkvist A; Fisone G
- Review: CELLULAR AND MOLECULAR LIFE SCIENCES. 2004;61(7-8):857-872Fisone G; Borgkvist A; Usiello A
Grants
- Swedish Research Council1 January 2025 - 31 December 2028The motor symptoms of Parkinson’s disease (PD) originate from dysfunctions in the basal ganglia, triggered by a reduction in dopaminergic tone. Dopaminergic therapy is effective initially, but with time, complicated side effects emerge. Tremor and gait disturbances are refractory symptoms, partially alleviated with deep brain stimulation (DBS) therapy. In rodent and primate models of PD, we have discovered a reduction in the potassium and chloride symporter (KCC2) in the substantia nigra reticulata (SNr), a promising DBS target for reducing freezing of gait in PD. This disruption causes impaired GABAergic inhibition of SNr, which may underlie problems in movement initiation. We hypothesize that DBS enhances KCC2 expression, suggesting KCC2-enhancing drugs as new therapeutic alternatives in PD. Firstly, we will examine how KCC2 regulates synaptic integration in SNr neurons. Next, we will determine if DBS of SNr inputs reduces parkinsonism by restoring KCC2 functionin a mouse model of PD. In parallel, by stimulating the subthalamic nucleus, we will determine if the reduction in KCC2 is triggered by glutamate release. Finally, we will examine the antiparkinsonian effect of drugs promoting KCC2 function using behavioral analyses. Recovery of synaptic function in the SNr will be examined by measuring SNr activity in mice with fiber photometry and GCaMP imaging. Altogether, this project investigates a new therapeutic option that may promote non-dopaminergic medications in PD.
- Swedish Research Council1 January 2017 - 31 December 2020
- Swedish Research Council1 July 2009 - 30 June 2011
Employments
- Principal Researcher, Department of Neuroscience, Karolinska Institutet, 2022-
Degrees and Education
- Doctor Of Philosophy, Department of neuroscience, Karolinska Institutet, 2008